|Home||» Products||» Ophthalmology medicines||» Ruxolitinib Tablets|
It is used in the treatment of intermediate or high-risk myelofibrosis, a type of myeloproliferative disorder that affects the bone marrow, and for polycythemia vera (PCV) when there has been an inadequate response to or intolerance of hydroxyurea.
Dosage and Administration:
Jakavi (Ruxolitinib ) is a pill, taken by mouth, with or without food. Take Jakavi (Ruxolitinib ) exactly as prescribed, even if you are feeling better. Swallow Jakavi (Ruxolitinib) tablets whole. Do not chew, crush or break.